Intratumorally injected mRNA c-Met-CAR-T cells caused only mild adverse effects but evoked a potent inflammatory response, followed by tumor necrosis and loss of c-Met immunoreactivity as assessed by immunohistochemistry [141]. This evidence concerns the gene MET and neoplasm.